SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  PSI Presents on Clinical Trial Feasibility

[June 23, 2014]

PSI Presents on Clinical Trial Feasibility

ZUG, Switzerland --(Business Wire)--

PSI CRO, a full-service contract research organization, announced today that Kasia Moscicka, Director Feasibility Research and Patient Recruitment Services, presented on the changing dynamic of clinical trial feasibility at recent PCMG meeting held in Lisbon, Portugal.

To coincide with the 10th anniversary of the PCMG conference, Ms. Moscicka, PSI's Director of Feasibility, gave a fascinating presentation discussing how the feasibility process has evolved over the last 10 years, why conducting thorough feasibility is more important today than it ever was and what we can all learn to ensure we handle the increasing complexity inherent in conducting clinical trial feasibility in a sophisticated and appropriate manner.

During her talk, Ms. Moscicka also presented feedback from a recent survey sent out to industry members to learn more about how different companies approach feasibility studies, what levl of control they allow CROs in terms of country/site selection & protocol adaptation, what return on investment do they feel feasibilities provide and what level of accountability for success they expect a CRO to take once they have performed a feasibility and how willing CROs are to do this.


The presentation evoked considerable interest from industry representatives. As inquiries and meeting requests keep arriving following the PCMG talk, be aware that PSI representatives will be available for consultation and further discussion at the upcoming Outsourcing in Clinical Trials UK & Ireland conference to be held on June 25th - 26th at the Royal Garden Hotel, Kensington.

About PSI CRO AG: PSI is a Swiss-based privately-owned, full-service contract research organization (CRO), operating globally. PSI's reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI's global reach supports the operations of clinical trials across multiple countries and continents. PSI is known to be highly selective about the work that they pursue. PSI has exceptionally high repeat and referral business rates, while maintaining minimal staff turnover indicative of its commitment to be the best CRO in the world as measured by its customers and its employees. Global headquarters are located in Zug (Zürich), Switzerland at 113a Baarerstrasse 6300. www.psi-cro.com


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy